30
May
2024
Merck Bets on the Eye, Merus Raises a Fortune, & Roche Leadership Change
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
30
May
2024
Recognizing 11 Asian-American Executives Shaping the Future of Biopharmaceuticals
As we celebrate the end of AAPI Heritage Month, we acknowledge the vital role that Asian American and Pacific Islander professionals have made in the biopharmaceutical industry. We are honored to present an update to our 2021 feature on 11 AAPI professionals shaping the future of biopharma, again selected for their commitment to solving health problems, integrity in leadership, and... Read More